Study: Activated Immune System Works in Some Cancer Patients
Activated Immune system attacks scaffolding around cancer cells causing tumor to fall apart
If your doctor belongs to our network of doctors, you are entitled to a discount. When ordering, please tell us the name of your doctor and we will check for you.
We accept all types of credit cards (credit, debit, pre-paid, etc.). Sorry, we don't accept other modes of payment.
We can also take your order over the phone. Call us if you would like to use this option.
To keep your privacy, your bank or credit card statements will only show the name of our parent company, not the product.
For your security, we will never call you and ask for your credit card number, or personal information.
See more details about Gene-Eden-VIR/Novirin in Package Insert.
Call us and ask about promotions
In 2010, about 43,140 people were diagnosed with pancreatic cancer, according
to the American Cancer Society; 36,800 died. According to an article on WebMD
that discusses a new study on Pancreatic Cancer and treatment, "A novel
approach to pancreatic cancer treatment that activates the immune system works
in some patients."
The Center for the Biology of Chronic Disease (CBCD) is very encouraged by
studies like these which show improvement in the survival of cancer patients.
Researcher Robert H. Vonderheide, MD, DPhil, an associate professor of
medicine in the division of hematology/oncology and the Abramson Family Cancer
Research Institute, University of Pennsylvania said, "The therapy is an
antibody. Instead of binding to the cancer, this antibody binds to a molecule
in the immune system, and that is CD40. Next, the immune system is activated,
allowing it to attack the so-called scaffolding around the cancer cells. The
scaffolding is destroyed and the tumor falls apart. The process is somewhat
like attacking a brick wall by dissolving the mortar in the wall."
The new approach extended overall survival by nearly two months compared to
Another study discussed in the scientific journal Acta Oncologica, showed how
treatment with the natural antiviral supplement Gene-Eden-VIR caused a
complete recovery of the immune system and an amazing 34% reduction in tumor
size in a patient with pancreatic cancer. The study was conducted at the
Center for the Biology of Chronic Disease by Hanan Polansky and Ido Dafni,
Acta Oncologica is a leading scientific journal in clinical oncology and
related disciplines, and the official journal of the five Nordic oncological
The CBCD has long advocated the need for people to maintain a healthy immune
system. The immune system is key in the body's defense against many different
chronic diseases, including cancers such as pancreatic cancer.
According to the WebMD website:
"If you're among the 1.5 million people in the United States diagnosed with
cancer each year, you may be considering taking vitamins and supplements for
cancer. Supplements, herbs, and extracts are increasingly used in integrative
Help strengthen the immune system
Help ease side effects of chemotherapy and radiation."
In simple terms, medical experts today highly recommend taking supplements to
help patients fight cancer.
Visit the CBCD website for more information on the
Center for the Biology of Chronic Disease.
Note: This press release was first issued by The Center for the
Biology of Chronic Disease (CBCD), a not-for-profit organization that specializes
in researching the biology of foreign DNA.